General and Abdominal Adiposity and Risk of Death in Europe



Similar documents
Karen Kovach M.S, R.D Chief Scientific Officer Weight Watchers International Inc.

The role of diet on the longevity of elderly Europeans: EPIC-Elderly

Appendix: Description of the DIETRON model

Do You Know Your GI Risks?

Analysing research on cancer prevention and survival. Diet, nutrition, physical activity and breast cancer survivors. In partnership with

Chapter 5 DASH Your Way to Weight Loss

The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery

Body Mass Index as a measure of obesity

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

Do You Know the Health Risks of Being Overweight?

WHO STEPwise approach to chronic disease risk factor surveillance (STEPS)

The benefits of prevention: healthy eating and active living

Steven Allender, Peter Scarborough, Viv Peto and Mike Rayner

Client Sex Facility Birth Date Height Weight Measured Sample Client Male (not specified) 00/00/ in lbs. 02/20/2016

Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D.

A Passage to India: Establishing a Cardiac Rehabilitation program in India s south-east

Diabetes mellitus is a chronic condition that occurs as a result of problems with the production and/or action of insulin in the body.

3.5% 3.0% 3.0% 2.4% Prevalence 2.0% 1.5% 1.0% 0.5% 0.0%

Body Composition & Longevity. Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ

Health at a Glance: Europe 2014

Trend tables. Health Survey for England. A survey carried out on behalf of the Health and Social Care Information Centre. Joint Health Surveys Unit

Your Results. For more information visit: Name: Date: In partnership with

Adult Weight Management Training Summary

Η δίαιτα στην πρόληψη του αγγειακού εγκεφαλικού επεισοδίου

International comparisons of obesity prevalence

Hoeveel zitten we en is dat erg?

Catholic Medical Center & Androscoggin Valley Hospital. Surgical Weight Loss Options For a Healthier Tomorrow

Obesity in the United States Workforce. Findings from the National Health and Nutrition Examination Surveys (NHANES) III and

Sophie Petersen, Viv Peto and Mike Rayner. British Heart Foundation Health Promotion Research Group Department of Public Health, University of Oxford

Healthy life resources for the cancer community. Tonight: Healthy Eating with Diane B. Wilson, EdD, RD. January 18, 2012

Protein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075

The Polyphenol Study. Effect of Dietary Polyphenols on Intestinal Microbiota, Intestinal Inflammation and Metabolic Syndrome

Diabetes. Gojka Roglic. Department of Chronic Diseases and Health Promotion. World Health Organization

DIET AND EXERCISE STRATEGIES FOR WEIGHT LOSS AND WEIGHT MAINTENANCE

Q&A on the carcinogenicity of the consumption of red meat and processed meat

The weight of the world.

A simple guide to classifying body mass index in children. June 2011

Appendix. Appendix Figure 1: Trends in age-standardized cardiometabolic (CVD and diabetes) mortality by country.

Mortality Assessment Technology: A New Tool for Life Insurance Underwriting

High Blood Cholesterol

Nutrition Assessment. Miranda Kramer, RN, MS Nurse Practitioner/Clinical Nurse Specialist

Now we ve weighed up your application for our protection products, it s only fair we talk you through our assessment process. More than anything, we

Liver Transplantation for Hepatocellular Carcinoma. John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco

Mortality in vegetarians and nonvegetarians: detailed findings from a collaborative analysis of 5 prospective studies 1 3

High Blood Pressure in People with Diabetes:

Statistics on Obesity, Physical Activity and Diet. England 2015

HEALTH MANAGEMENT PLAN PROGRAMME

Sedentarity and Exercise in the Canadian Population. Angelo Tremblay Division of kinesiology

Underwriting Critical Illness Insurance: A model for coronary heart disease and stroke

Draft comprehensive global monitoring framework and targets for the prevention and control of noncommunicable diseases

evaluation of cancer hazards Robert A Baan PhD The IARC MONOGRAPHS International Agency for Research on Cancer Lyon, France

Using Family History to Improve Your Health Web Quest Abstract

Diabetes and Obesity. The diabesity epidemic

The Obesity Explosion: How Did We Get Here and Where Are We At?

Maintaining Healthy Body Mass Index (BMI) Through Physical Activity and Diet Pitfalls of Fad Dieting. Julia Sosa, MS,RD,LD ADPH

Section C. Diet, Food Production, and Public Health

Weight Loss Surgery DA participants- 18 months later. By: Caitlyn Patrick and Evan Morgan

HEALTH RISK ASSESSMENT (HRS) QUESTIONNAIRE

European Cardiovascular Disease Statistics edition

Dr. Paul Naughton, Teagasc Dr. Sinéad McCarthy, Teagasc Dr. Mary McCarthy, UCC

Prevention of and the Screening for Diabetes Part I Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner January 19, 2012

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

Counting all the costs: the economic costs of comorbidities

Barriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness

2.5 Cancer of the liver

Michael E Dewey 1 and Martin J Prince 1. Lund, September Retirement and depression. Michael E Dewey. Outline. Introduction.

What women can do to optimise their health during pregnancy and that of their baby Claire Roberts

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007

Health Survey for England 2014: Health, social care and lifestyles. Summary of key findings

Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis

GA-3 Disaster Medical Assistance Team. Physical Fitness Guide

EUROASPIRE II. European Action on Secondary and Primary Prevention through Intervention to Reduce Events

What is a Heart Attack? 1,2,3

EMR Nutrition Data Set Indicators: Units of Measurement

Cohort Studies. Sukon Kanchanaraksa, PhD Johns Hopkins University

Breast Cancer a Health Economic Overview

CHEM 1406 BSA/BMI Measurement Laboratory (revised 01/03//06) BSA, Body Surface Area

GENERAL INTRODUCTION

Diabetes Complications

REFERENCE CODE GDHCER PUBLICAT ION DATE AUGUST 2014 RENAL CELL CARCINOMA - EPIDEMIOLOGY FORECAST TO 2023

1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME

Obesity and ethnicity

Risk of alcohol. Peter Anderson MD, MPH, PhD, FRCP Professor, Alcohol and Health, Maastricht University Netherlands. Zurich, 4 May 2011

Transcription:

Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke General and Abdominal Adiposity and Risk of Death in Europe Tobias Pischon Department of Epidemiology German Institute of Human Nutrition Potsdam-Rehbruecke

Prevalence of Obesity in Europe (Men) Based on reports with direct measurement of weight and height (with the exception of France) Age range and time of data collection may vary across countries Berghoefer, et al. BMC Public Health 2008

Classification of Overweight and Obesity by BMI BMI = Body weight (kg) Height 2 (m 2 ) Classification BMI (kg/m 2 ) Underweight < 18.5 Normal weight 18.5 24.9 Overweight 25.0 29.9 Obesity Grade I 30.0 34.9 Obesity Grade II 35.0 39.9 Obesity Grade III 40.0

Risk of Chronic Disease (Men) Normal weight Overweight Obesity Grade I Obesity Grade II/III Type 2 diabetes 1 (reference) 3.5 11.2 23.4 Gallstones 1 (reference) 1.4 2.3 2.9 Hypertension 1 (reference) 1.7 2.7 3.0 High cholesterol levels 1 (reference) 1.3 1.2 1.3 Heart disease 1 (reference) 1.5 2.0 2.2 Stroke 1 (reference) 1.2 2.0 2.3 Field et al., Arch Intern Med 2001

Relative and Attributable Risk of Cancer Tumor Overweight Relative risk Obesity Attributable Risk (EU) Colorectal cancer (men) 1.5 2.0 28 % Colorectal cancer (women) 1.2 1.5 14 % Postmenopausal breast cancer 1.3 1.5 17 % Endometrial cancer 2.0 3.5 45 % Renal cell cancer 1.5 2.5 31 % Oesophageal cancer (adenocarcinoma) 2.0 3.0 43 % Pancreatic cancer 1.3 1.7 19 % Calle & Kaaks, Nat Rev Cancer 2004

Causes of Death in Germany (% of All Deaths in 2004; Total: 818 271) Statistisches Bundesamt (Hrsg.): Datenreport 2006

Survival Curves According to BMI Groups in Patients With Heart Failure The Obesity Paradox Overall Survival Survival Time (Month) Curtis et al., Arch Intern Med 2005

Body Fat Distribution Patterns Gluteal-femoral Fat Distribution Abdominal Fat Distribution - More prevalent in women - Lower risk of metabolic abnormalities - More prevalent in men - Higher risk of metabolic abnormalities

Relative Risk of Colon Cancer According to BMI or Waist Circumference (EPIC-Study) Men p trend =0.006 P (interaction BMI x sex) =0.04 Women p trend =0.40 Body Mass Index Men p trend =0.001 P (interaction waist circumference x sex) =0.48 Women p trend =0.008 Waist circumference N=368,277; 6.1 years of follow-up; 984 incident cases of colon cancer Adjusted for age, study center, smoking status, education, alcohol consumption, physical activity, fiber intake, and consumption of red and processed meat, fish and shellfisch, and fruits and vegetables Pischon et al., J Natl Cancer Inst 2006

European Prospective Investigation into Cancer and Nutrition (EPIC) 23 study centers in 10 European countries Recruitment 1992-2000 519,978 participants Age 25-70 years TROMSO UMEA Exclusions: Weight or height not measured No information on physical activity No questionnaire completed Ratio of energy intake to energy expenditure above 99 th or below 1 st percentile Chronic diseases at baseline (cancer, heart disease, stroke) Remaining study population: 359,387 participants AARHUS MALMO COPENHAGEN CAMBRIDGE UTRECHT POTSDAM OXFORD BILTHOVEN OVIEDO SAN SEBASTIAN PAMPLONA PARIS I.A.R.C. MURCIA GRANADA LYON BARCELONA HEIDELBERG MILAN TURIN FLORENCE NAPLES RAGUSA ATHENS

Results: Study Participants Country Number of participants Mean age (years) Mean follow-up time (years) Number of deaths Men Women Men Women Men Women Men Women France 0 19.589-53 - 12,9 0 348 Italy 13.648 30.150 50 51 9,1 9,2 370 516 Spain 14.787 24.455 51 48 10,9 10,8 675 430 UK 21.365 50.828 52 48 9,2 9,4 1.543 1.673 Netherlands 9.511 25.919 43 51 10,6 9,8 326 820 Greece 10.025 14.722 52 53 7,0 7,3 686 426 Germany 20.453 27.366 52 49 8,3 8,3 868 425 Sweden 9.521 13.798 59 57 11,4 11,4 1.196 845 Denmark 25.042 28.208 57 57 9,9 10,1 2.141 1.435 Total 124.352 235.035 53 51 9,5 9,8 7.805 6.918 Pischon et al., N Engl J Med 2008

Association of BMI With Risk of Death in EPIC Men Women Relative Risk 25,3 24,3 BMI BMI N=359,387; 9.7 years of follow-up; 14,723 deaths Stratified by age and study center with adjustment for smoking status, education, alcohol consumption, physical activity, and height Pischon et al., N Engl J Med 2008

Association of Waist Circumference With Risk of Death in EPIC Men Women Relative Risk Waist circumference Waist circumference N=359,387; 9.7 years of follow-up; 14,723 deaths Stratified by age and study center with adjustment for smoking status, education, alcohol consumption, physical activity, and height Pischon et al., N Engl J Med 2008

Association of Waist Circumference With Risk of Death After Adjustment for BMI Men Women Relative Risk Waist circumference Waist circumference N=359,387; 9.7 years of follow-up; 14,723 deaths Stratified by age and study center with adjustment for smoking status, education, alcohol consumption, physical activity, height, and BMI Pischon et al., N Engl J Med 2008

BMI, Waist Circumference and Risk of Death Men Women p interaction =0.03 p interaction =0.03 Relative Risk Relative risk 2.5 2.0 1.5 1.0 0.5 BMI, kg/m 2 Waist circumference Body Mass Index Q1 Q2 Q3 Q4 Q5 Tertile 1 Tertile 2 Tertile 3 BMI 1.3 1.2 1.1 1.0 0.92.5 0.8 0.72.0 0.6 0.5 0.41.5 0.3 0.2 0.1 0.01.0-0.1-0.2-0.3-0.4-0.5-0.6-0.70.5 Relative risk Waist circumference Q1 Q2 Q3 Q4 Q5 Tertile 1 Tertile 2 Tertile 3 Body Mass Index <24.9 24.9-<27.7 27.7 <23.0 23.0-<26.6 26.6 BMI 1.3 1.2 1.1 1.0 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0.0-0.1-0.2-0.3-0.4-0.5-0.6-0.7 N=359,387; 9.7 years of follow-up; 14,723 deaths Stratified by age and study center with adjustment for smoking status, education, alcohol consumption, physical activity, and height Pischon et al., N Engl J Med 2008

Current Classification of Overweight and Obesity and Associated Disease Risk Classification BMI (kg/m 2 ) Disease Risk According to Normal Weight and Waist Circumference Men 102 cm Women 88 cm Men > 102 cm Women > 88 cm Underweight <18.5 - - Normal weight 18.5-24.9 - - Overweight 25.0-29.9 Increased High Obesity Grade I 30.0-34.9 High Very High Obesity Grade II 35.0-39.9 Very High Very High Obesity Grade III 40.0 Extremely High Extremely high Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report - NIH PUBLICATION NO. 98-4083. Bethesda: National Institutes of Health; 1998

Association of BMI With Risk of Death in EPIC Men Women Relative Risk BMI BMI N=359,387; 9.7 years of follow-up; 14,723 deaths Stratified by age and study center with adjustment for smoking status, education, alcohol consumption, physical activity, and height Pischon et al., N Engl J Med 2008

Association of Waist Circumference With Risk of Death After Adjustment for BMI Men Women Relative Risk Waist circumference Waist circumference N=359,387; 9.7 years of follow-up; 14,723 deaths Stratified by age and study center with adjustment for smoking status, education, alcohol consumption, physical activity, height, and BMI Pischon et al., N Engl J Med 2008

Expected and Observed 5-Year Risk of Death (Men) 5-year risk according to model with BMI <2.5% 5-year risk according to model with BMI and waist circumference <2.5% 2.5-<5.0% 5.0-<7.5% >=7.5% n 86,057 1,812 0 0 Total reclassified (%) Participants classified in stratum, % 97.9 2.1 0 0 2.1 Observed 5-year risk, % 0.9 2.4 - - 2.5-<5.0% n 1,943 17,403 950 1 Participants classified in stratum, % 9.6 85.7 4.7 0 14.3 Observed 5-year risk, % 2.2 3.5 5.5 0 5.0-<7.5% n 0 892 4,998 577 Participants classified in stratum, % 0 13.8 77.3 8.9 22.7 Observed 5-year risk, % - 4.7 7.0 7.8 >=7.5% n 0 2 563 5,640 Participants classified in stratum, % 0 0 9.1 90.9 9.1 Observed 5-year risk, % - 0 7.8 14.2 Pischon et al., N Engl J Med 2008

Calibration, Discrimination and Reclassification (Men) Model with BMI Model with BMI and Waist circumference Model with BMI and Waist-hip-ratio Nagelkerke s R 2, % 15.52 15.70 15.68 Hosmer-Lemeshow Statistic χ 2 11.91 14.18 10.09 p 0.16 0.08 0.26 C-statistic 0.7948 0.7961* 0.7964* Net reclassification index - 0.00487 (p=0.41) 0.00042 (p=0.95) Integrated discrimination index - 0.00095 (p<0.0001) 0.00075 (p=0.004) *p<0.05 versus model without waist circumference and waist-hip-ratio p<0.05 versus model with waist circumference Pischon et al., N Engl J Med 2008

Summary and Conclusions General and abdominal adiposity are both associated with a higher risk of death J-shaped association between BMI and risk of death with higher risk in the lower and upper BMI categories than in the middle category Adjusted for BMI, there is an almost linear association between waist circumference and risk of death Positive association between abdominal adiposity and mortality is stronger at lower BMI levels than at higher BMI levels Measurement of waist circumference or waist-hip-ratio improves the prediction of mortality risk The results support the use of waist circumference or waist-to-hip ratio in addition to BMI in the assessment of the risk of death, particularly among persons with a low BMI